Comprehensive analysis of glycometabolism-related genes reveals PLOD2 as a prognostic biomarker and therapeutic target in gastric cancer

被引：0
|
作者：
Wanchun Ye [1 ]
Xiaolei Zhang [2 ]
Zhongjie Tang [1 ]
Yufeng Hu [1 ]
Yuanliang Zheng [1 ]
Yuping Yuan [1 ]
机构：
[1] The Dingli Clinical College of Wenzhou Medical University,Department of Clinical Laboratory
[2] Wenzhou Central Hospital,undefined
[3] The Second Affiliated Hospital of Shanghai University,undefined
[4] Jinan Fourth People’s Hospital,undefined
来源：
BMC Gastroenterology | / 25卷 / 1期
关键词：
Gastric cancer; Glycometabolism; PLOD2; Immune evasion; PI3K/AKT/mTOR pathway; Prognostic model; Therapeutic resistance;
D O I：
10.1186/s12876-025-03878-z
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarker
    Chen, Wu
    Zou, Fan
    Song, Tianbao
    Xia, Yuqi
    Xing, Ji
    Rao, Ting
    Zhou, Xiangjun
    Ning, Jinzhuo
    Zhao, Sheng
    Yu, Weimin
    Cheng, Fan
    AGING-US, 2023, 15 (21): : 11891 - 11917
  • [42] Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment
    Zhu, Zhipeng
    Ye, Weipeng
    Wu, Xiaofang
    Lin, Sihao
    Xu, Jiuhua
    Li, Lulu
    Li, Jiayi
    Wang, Haibin
    Huang, Zhengjie
    BIOSCIENCE REPORTS, 2021, 41 (01)
  • [43] Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins
    Rui Gou
    Liancheng Zhu
    Mingjun Zheng
    Qian Guo
    Yuexin Hu
    Xiao Li
    Juanjuan Liu
    Bei Lin
    Journal of Translational Medicine, 17
  • [44] Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins
    Gou, Rui
    Zhu, Liancheng
    Zheng, Mingjun
    Guo, Qian
    Hu, Yuexin
    Li, Xiao
    Liu, Juanjuan
    Lin, Bei
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
  • [45] Initial clinical and experimental analyses of ALDOA in gastric cancer, as a novel prognostic biomarker and potential therapeutic target
    Liqiao Chen
    Zizhen Wu
    Jiamei Guo
    Xinyu Wang
    Zhenzhen Zhao
    Han Liang
    Rupeng Zhang
    Jingyu Deng
    Clinical and Experimental Medicine, 2023, 23 : 2443 - 2456
  • [46] Initial clinical and experimental analyses of ALDOA in gastric cancer, as a novel prognostic biomarker and potential therapeutic target
    Chen, Liqiao
    Wu, Zizhen
    Guo, Jiamei
    Wang, Xinyu
    Zhao, Zhenzhen
    Liang, Han
    Zhang, Rupeng
    Deng, Jingyu
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (06) : 2443 - 2456
  • [47] Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma
    Fu, Bidong
    Zhou, Minqin
    Song, Gelin
    Zeng, Hong
    Gong, Yiyang
    Jiang, Yike
    Ke, Yun
    Huang, Da
    Peng, Hong
    Li, Qing
    AGING-US, 2023, 15 (07): : 2734 - 2771
  • [48] Analysis of UROC4 as a new prognostic biomarker and therapeutic target for oral cancer
    Daigo, Kayo
    Takano, Atsushi
    Yoshitake, Yoshihiro
    Shinohara, Msanori
    Daigo, Yataro
    Tohnai, Iwai
    Murakami, Yoshinori
    Maegawa, Jiro
    CANCER SCIENCE, 2018, 109 : 215 - 215
  • [49] Multivariate Cox regression analysis of prognostic genes and therapeutic mechanisms of gastric cancer
    Xiao, Yangyang
    Zhong, Zhiru
    Yang, Chunli
    Lin, Zhiying
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [50] Comprehensive analysis of EML2 as a prognostic biomarker in colon cancer
    Sun, Yanjun
    Han, Lin
    Sun, Dengqun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2024, 17 (01): : 1 - 12
12345